Concepedia

Terry R. Van Vleet

TR

Statistics

Publications

22

Citations

1.2K

H-Index

15

Active since

2001

Affiliations

AbbVie (United States)(Current)

Utah State University

Bristol-Myers Squibb (United States)

UCB Pharma (United States)

Bristol-Myers Squibb (Germany)

Terry R. Van Vleet is an author at AbbVie (United States) specializing in medicine, pharmacology, and toxicology.

ORCID

Top concepts

Publications per year

2001–2023

22

Publications

22

Comparison of RNA-Seq and Microarray Gene Expression Platforms for the Toxicogenomic Evaluation of Liver From Short-Term Rat Toxicity Studies

Mohan Rao, Terry R. Van Vleet, Rita Ciurlionis et al. · Frontiers in Genetics · 2019 · 258 citations · Full text

Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction

David D. Arrington, Terry R. Van Vleet, Rick G. Schnellmann · American Journal of Physiology-Cell Physiology · 2006 · 184 citations

, , +19

Novel Computational Approach to Predict Off-Target Interactions for Small Molecules

Mohan Rao, Rishi Gupta, Michael J. Liguori et al. · Frontiers in Big Data · 2019 · 107 citations · Full text

Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications

Kristin Fabre, Brian R. Berridge, William R. Proctor et al. · Lab on a Chip · 2020 · 105 citations

Towards in vitro models for reducing or replacing the use of animals in drug testing

David M. Stresser, Anna K. Kopec, Philip Hewitt et al. · Nature Biomedical Engineering · 2023 · 75 citations

, , +11

1–5 of 22